SM
SGMO

Sabby Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Sabby Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-878
Closed -$1.25M – 146
2018
Q2 		$1.25M Buy
878
+649
+283% +$10.8K 0.19% 54
2018
Q1 		$435K Sell
229
-5,811
-96% -$124K 0.05% 99
2017
Q4 		$9.91M Buy
6,040
+2,056
+52% +$30.6K 0.9% 22
2017
Q3 		$5.98M Buy
3,984
+92
+2% +$1.02K 0.39% 34
2017
Q2 		$3.42M Buy
3,892
+399
+11% +$2.56K 0.22% 50
2017
Q1 		$1.82M Sell
3,493
-2,684
-43% -$10.8K 0.1% 98
2016
Q4 		$1.88M Buy
6,177
+566
+10% +$2.06K 0.11% 106
2016
Q3 		$2.6M Buy
5,611
+1,211
+28% +$6.16K 0.1% 107
2016
Q2 		$2.55M Buy
4,400
+1,395
+46% +$8.89K 0.13% 89
2016
Q1 		$1.82M Buy
3,005
+1,780
+145% +$10.7K 0.09% 109
2015
Q4 		$1.12M Buy
1,225
+1,010
+470% +$7.78K 0.06% 171
2015
Q3 		$121K Sell
215
-8,906
-98% -$73.4K 0.01% 361
2015
Q2 		$10.1M Sell
9,121
-263
-3% -$3.39K 0.37% 58
2015
Q1 		$14.7M Sell
9,384
-784
-8% -$12.1K 0.61% 36
2014
Q4 		$15.5K Buy
10,168
+156
+2% +$1.89K 0.49% 28
2014
Q3 		$10.8K Hold
10,012
– – 0.41% 41
2014
Q2 		$15.3M Buy
10,012
+2
+0% +$29 0.66% 28
2014
Q1 		$18.1M Buy
+10,010
New +$193K 1.01% 24

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabby Management's SGMO Position: Q1 2019 in Review

Sabby Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2019, closing a stake of 81,161 shares — an estimated $932K sold.

Sabby Management first reported a position in SGMO in Q1 2014 and held it in 15 quarters. The position peaked at $6.77M in Q2 2014. 187 funds tracked by Wall St. Rank hold SGMO as of Q1 2019.

  • Sabby Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2019 after selling out during the quarter.
  • Sabby Management sold 81,161 SANGAMO THERAPEUTICS INC shares in Q1 2019, an estimated $932K.
  • Sabby Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 15 quarters.
  • Sabby Management's SANGAMO THERAPEUTICS INC position peaked at $6.77M in Q2 2014.
  • 187 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2019.

Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.